Have a personal or library account? Click to login

Ultrasound targeted microbubble destruction-mediated gene delivery system: application to therapy for ocular disease

Open Access
|Feb 2017

References

  1. 1. Singh VK, Tripathi P. Gene therapy in ocular diseases. Indian J Ophthalmol. 2002; 50:173-81.
  2. 2. Marshall E. Gene therapy’s growing pains. Science. 1995; 269:1050, 1052-5.10.1126/science.76525527652552
  3. 3. Felgner PL, Barenholz Y, Behr JP, et al. Nomenclature for synthetic gene delivery systems. Hum Gene Ther. 1997; 8:511-2.10.1089/hum.1997.8.5-5119095402
  4. 4. Marshall E. Gene therapy death prompts review of adenovirus vector. Science. 1999; 286:2244-5.10.1126/science.286.5448.224410636774
  5. 5. Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med. 2002; 346:1185-93.10.1056/NEJMoa01261611961146
  6. 6. Grisham J. Inquiry into gene therapy widens. Nat Biotechnol. 2000; 18:254-5.10.1038/7367310700127
  7. 7. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science. 1990; 247:1465-8.10.1126/science.16909181690918
  8. 8. Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A. Longterm persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet. 1992; 1: 363-9.10.1093/hmg/1.6.3631301910
  9. 9. Felgner PL, Gadek TR, Holm M, et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA. 1987; 84:7413-7.10.1073/pnas.84.21.74132993062823261
  10. 10. Stechschulte SU, Joussen AM, von Recum HA, et al. Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest Ophthalmol Vis Sci. 2001; 42:1975-9.
  11. 11. Hernot S, Klibanov AL. Microbubbles in ultrasoundtriggered drug and gene delivery. Adv Drug Deliv Rev. 2008; 60:1153-66.10.1016/j.addr.2008.03.005272015918486268
  12. 12. Bekeredjian R, Chen S, Pan W, Grayburn PA, Shohet RV. Effects of ultrasound-targeted microbubble destruction on cardiac gene expression. Ultrasound Med Biol. 2004; 30:539-43.10.1016/j.ultrasmedbio.2003.12.00615121256
  13. 13. Guo DP, Li XY, Sun P, et al. Ultrasound/microbubble enhances foreign gene expression in ECV304 cells and murine myocardium. Acta Biochim Biophy Sin. 2004; 36:824-31.10.1093/abbs/36.12.824
  14. 14. Hu YZ, Zhu JA, Jiang YG, Hu B. Ultrasound microbubble contrast agents: application to therapy for peripheral vascular disease. Adv Ther. 2009; 26:425-34.10.1007/s12325-009-0020-y
  15. 15. Zhang Q, Wang Z, Ran H, et al. Enhanced gene delivery into skeletal muscles with ultrasound and microbubble techniques. Acad Radiol. 2006; 13:363-7.10.1016/j.acra.2005.11.003
  16. 16. Wang JF, Wang JB, Chen H, et al. Ultrasound-mediated microbubble destruction enhances gene transfection in pancreatic cancer cells. Adv Ther. 2008; 25:412-21.10.1007/s12325-008-0051-9
  17. 17. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol. 1968; 3:356-66.10.1097/00004424-196809000-00011
  18. 18. Feinstein SB, Ten Cate FJ, Zwehl W, et al. Twodimensional contrast echocardiography: in vitro development and quantitative-analysis of echo contrast agents. J Am Coll Cardiol. 1984; 3:14-20.10.1016/S0735-1097(84)80424-6
  19. 19. Feinstein SB, Cheirif J, Ten Cate FJ, et al. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical-results. J Am Coll Cardiol. 1990; 16:316-24.10.1016/0735-1097(90)90580-I
  20. 20. Korpanty G, Grayburn PA, Shohet RV, Brekken RA. Targeting vascular endothelium with avidin microbubbles. Ultrasound Med Biol. 2005; 31:1279-83.10.1016/j.ultrasmedbio.2005.06.001
  21. 21. Frenkel PA, Chen S, Thai T, Shohet RV, Grayburn PA. DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med Biol. 2002; 28:817-22.10.1016/S0301-5629(02)00518-5
  22. 22. Lentacker I, De Geest BG, Vandenbroucke RE, et al. Ultrasound-responsive polymer-coated microbubbles that bind and protect DNA. Langmuir. 2006; 22:7273-8.10.1021/la060382816893226
  23. 23. Porter TR, Xie F. Visually discernible myocardial echocardiographic contrast after intravenous injection of sonicated dextrose albumin microbubbles containing high molecular weight, less soluble gases. J Am Coll Cardiol. 1995; 25:509-15.10.1016/0735-1097(94)00376-2
  24. 24. Correas JM, Quay SD. EchoGen emulsion: a new ultrasound contrast agent based on phase shift colloids. Clin Radiol. 1996; 51(suppl.1):11-4.
  25. 25. Schneider M, Arditi M, Barrau MB, et al. BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol. 1995; 30:451-5.10.1097/00004424-199508000-00001
  26. 26. Laing ST, McPherson DD. Cardiovascular therapeutic uses of targeted ultrasound contrast agents. Cardiovasc Res. 2009; 83:626-35.10.1093/cvr/cvp192
  27. 27. Skyba DM, Price RJ, Linka AZ, Skalak TC, Kaul S. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation. 1998; 98:290-3.10.1161/01.CIR.98.4.290
  28. 28. Lawrie A, Brisken AF, Francis SE, et al. Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. Circulation.1999; 99:2617-20.10.1161/01.CIR.99.20.2617
  29. 29. Ward M, Wu J, Chiu JF. Ultrasound-induced cell lysis and sonoporation enhanced by contrast agents. J Acoust Soc Am. 1999; 105:2951-7.10.1121/1.426908
  30. 30. Wu J, Ross JP, Chiu JF. Reparable sonoporation generated by microstreaming. J Acoust Soc Am. 2002; 111:1460-4.10.1121/1.1420389
  31. 31. Tachibana K, Uchida T, Ogawa K, Yamashita N, Tamura K. Induction of cell-membrane porosity by ultrasound. Lancet. 1999; 353:1409.10.1016/S0140-6736(99)01244-1
  32. 32. Ogawa K, Tachibana K, Uchida T, et al. High-resolution scanning electron microscopic evaluation of cellmembrane porosity by ultrasound. Med Electron Microsc. 2001; 34:249-53.10.1007/s00795010002211956998
  33. 33. van Wamel A, Bouakaz A, Versluis M, de Jong N. Micromanipulation of endothelial cells: ultrasoundmicrobubble- cell interaction. Ultrasound Med Biol. 2004; 30:1255-8.10.1016/j.ultrasmedbio.2004.07.01515550330
  34. 34. Miller DL, Gies RA. The interaction of ultrasonic heating and cavitation in vascular bioeffects on mouse intestine. Ultrasound Med Biol. 1998; 24:123-8.10.1016/S0301-5629(97)00209-3
  35. 35. Farjo R, Skaggs J, Quiambao AB, Cooper MJ, Naash MI. Efficient non-viral ocular gene transfer with compacted DNA nanoparticles. PLoS One. 2006; 1:e38.10.1371/journal.pone.0000038
  36. 36. Martin KR, Quigley HA. Gene therapy for optic nerve disease. Eye. 2004; 18:1049-55.10.1038/sj.eye.6701579
  37. 37. Zderic V, Clark JI, Martin RW, Vaezy S. Ultrasoundenhanced transcorneal drug delivery. Cornea. 2004; 23: 804-11.10.1097/01.ico.0000134189.33549.cc
  38. 38. Zderic V, Clark JI, Vaezy S. Drug delivery into the eye with the use of ultrasound. J Ultrasound Med. 2004; 23:1349-59.10.7863/jum.2004.23.10.1349
  39. 39. Zderic V, Vaezy S, Martin RW, Clark JI. Ocular drug delivery using 20-kHz ultrasound. Ultrasound Med Biol. 2002; 28:823-9.10.1016/S0301-5629(02)00515-X
  40. 40. Sonoda S, Tachibana K, Uchino E, et al. Gene transfer to corneal epithelium and keratocytes mediated by ultrasound with microbubbles. Invest Ophthalmol Vis Sci. 2006; 47:558-64.10.1167/iovs.05-088916431951
  41. 41. Wu Y, Du LF, Chen YD, Wang HP, Wang F. SonoVue and ultrasound mediated pEGFP-N1 transfection to mouse cornea in vivo study. Chin J Ultrasonogr. 2008; 17:350-3.
  42. 42. Yamashita T, Sonoda S, Suzuki R, et al. A novel bubble liposome and ultrasound-mediated gene transfer to ocular surface: RC-1 cells in vitro and conjunctiva in vivo. Exp Eye Res. 2007; 85:741-8.10.1016/j.exer.2007.08.00617889849
  43. 43. Li W, Liu S, Ren J, Xiong H, Yan X, Wang Z. Gene transfection to retinal ganglion cells mediated by ultrasound microbubbles in vitro. Acad Radiol. 2009; 16:1086-94.10.1016/j.acra.2009.03.01919541507
  44. 44. Mori K, Duh E, Gehlbach P, et al. Pigment epitheliumderived factor inhibits retinal and choroidal neovascularization. J Cell Physiol. 2001; 188:253-63.10.1002/jcp.111411424092
  45. 45. Duh EJ, Yang HS, Suzuma I, et al. Pigment epitheliumderived factor suppresses ischemia-induced retinal neovascularization and VEGF induced migration and growth. Invest Ophthalmol Vis Sci. 2002; 43:821-9.
  46. 46. Lai CC, Wu WC, Chen SL, et al. Suppression of choroidal neovascularization by adenoassociated virus vector expressing angiostatin. Invest Ophthalmol Vis Sci. 2001; 42:2401-7.
  47. 47. Takahashi T, Nakamura T, Hayashi A, et al. Inhibition of experimental choroidal neovascularization y overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells. Am J Ophthalmol. 2000; 130:774-81.10.1016/S0002-9394(00)00772-8
  48. 48. Zhou XY, Liao Q, Pu YM, et al. Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization. Chin Med J. 2009; 122:2711-7.
  49. 49. Zhou XY, Deng X, Wang ZG. Experimental research of transfection efficiency for EGFP plasmid transfected into retinoblastoma cells by ultrasound microbubble intensifier. Chinese J Ultrasound Med. 2006; 122: 564-6.
  50. 50. Surace EM, Auricchio A. Versatility of AAV vectors for retinal gene transfer. Vision Res. 2008; 48:353-9.10.1016/j.visres.2007.07.027
  51. 51. Martin KR, Klein RL, Quigley HA. Gene delivery to the eye using adeno-associated viral vectors. Methods. 2002; 28:267-75.10.1016/S1046-2023(02)00232-3
  52. 52. Daya S, Berns KI. Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev. 2008; 21:583-93.10.1128/CMR.00008-08257015218854481
  53. 53. Li HL, Zheng XZ, Wang HP, Li F, Wu Y, Du LF. Ultrasound-targeted microbubble destruction enhances AAV-mediated gene transfection in human RPE cells in vitro and rat retina in vivo. Gene Ther. 2009; 16:1146-53.10.1038/gt.2009.8419571889
  54. 54. Zheng XZ, Li HL, Du LF, Wang HP, Gu Qing. In vivo and in vitro effects of ultrasound or/and microbubbles on recombinant adeno-associated virus-mediated transgene expression in the retina. Asian Biomed. 2009; 3:497-506.
  55. 55. Baum C, Kustikova O, Modlich U, Li Z, Fehse B. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther. 2006; 17:253-63.10.1089/hum.2006.17.25316544975
  56. 56. Halbert CL, Miller AD, McNamara S, et al. Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors. Hum Gene Ther. 2006; 17:440-7.10.1089/hum.2006.17.440429289016610931
  57. 57. Raper SE, Chirmule N, Lee FS, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab. 2003; 80: 148-58.10.1016/j.ymgme.2003.08.01614567964
  58. 58. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003; 4:346-58.10.1038/nrg106612728277
  59. 59. Cai X, Conley S, Naash M. Nanoparticle Applications in Ocular Gene Therapy. Vision Res. 2008; 48:319-24.10.1016/j.visres.2007.07.012242334517825344
  60. 60. Bejjani RA, BenEzra D, Cohen H, et al. Nanoparticles for gene delivery to retinal pigment epithelial cells. Mol Vis. 2005; 11:124-32.
  61. 61. de la Fuente M, Seijo B, Alonso MJ. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. Invest Ophthalmol Vis Sci. 2008; 49:2016-24.10.1167/iovs.07-1077
  62. 62. Chappell JC, Song J, Burke CW, Klibanov AL, Price RJ. Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis. Small. 2008; 4:1769-77.10.1002/smll.200800806
  63. 63. Vancraeynest D, Havaux X, Pouleur AC, et al. Myocardial delivery of colloid nanoparticles using ultrasound-targeted microbubble destruction. Eur Heart J. 2006; 27:237-45.10.1093/eurheartj/ehi479
  64. 64. Lin CY, Liu TM, Chen CY, Huang YL, Huang WK, Sun CK, Chang FH, Lin WL. Quantitative and qualitativeinvestigation into the impact of focused ultrasound with microbubbles on the triggered release of nanoparticles from vasculature in mouse tumors. J Control Release. 2010; 146:291-8.10.1016/j.jconrel.2010.05.033
  65. 65. Chumakova OV, Liopo AV, Andreev VG, et al. Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo. Cancer Lett. 2008; 261:215-25.10.1016/j.canlet.2007.11.023
  66. 66. Larina IV, Evers BM, Ashitkov TV, Bartels C, Larin KV, Esenaliev RO. Enhancement of drug delivery in tumors by using interaction of nanoparticles with ultrasound radiation. Technol Cancer Res Treat. 2005; 4:217-26.10.1177/153303460500400211
  67. 67. Larina IV, Evers BM, Esenaliev RO. Optimal drug and gene delivery in cancer cells by ultrasound-induced cavitation. Anticancer Res. 2005; 25:149-56.
  68. 68. Pitkänen L, Pelkonen J, Ruponen M, Rönkkö S, Urtti A. Neural retina limits the nonviral gene transfer to retinal pigment epithelium in an in vitro bovine eye model. AAPS J. 2004; 6:e25.10.1208/aapsj060325
  69. 69. Peeters L, Lentacker I, Vandenbroucke RE, et al. Can Ultrasound Solve the Transport Barrier of the Neural Retina? Pharm Res. 2008; 25:2657-65.10.1007/s11095-008-9684-2
  70. 70. Cunha-Vaz J. The blood-ocular barriers. Surv Ophthalmol. 1979; 23:279-96.10.1016/0039-6257(79)90158-9
  71. 71. Meairs S, Alonso A. Ultrasound, microbubbles and the blood-brain barrier. Prog Biophys Mol Biol. 2007; 93:354-62.10.1016/j.pbiomolbio.2006.07.01916959303
  72. 72. Sheikov N, McDannold N, Vykhodtseva N, Jolesz F, Hynynen K. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles.Ultrasound Med Biol. 2004; 30: 979-89.10.1016/j.ultrasmedbio.2004.04.01015313330
  73. 73. Xu Y, Zhou XY, Wang ZG, Li XS. Experimental study on transferring EGFP gene into the retina of rat mediated by microbubbles. Chin J Med Imaging Technol. 2007; 23:188-90.
  74. 74. Saito K, Miyake K, McNeil PL, Kato K, Yago K, Sugai N. Plasma membrane disruption underlies injury of the corneal endothelium by ultrasound. Exp Eye Res. 1999; 68:431-7. 10.1006/exer.1998.062610192800
DOI: https://doi.org/10.5372/1905-7415.0505.077 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 577 - 587
Published on: Feb 4, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2017 Jing Du, Lian Fang Du, Feng Hua Li, Xiao Zhi Zheng, Hong Li Li, Qiu Sheng Shi, Ying Wu, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.